Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Osteopore Ltd. ( (AU:OSX) ) just unveiled an update.
Osteopore Limited has released its consolidated annual report for the year ended 31 December 2025, detailing the corporate structure and oversight of the group. The report highlights the company’s governance framework, including its board composition, company secretary, registered office, share registry, and external auditor, underscoring the formal corporate infrastructure that supports its ongoing operations and engagement with shareholders.
The most recent analyst rating on (AU:OSX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Osteopore Ltd. stock, see the AU:OSX Stock Forecast page.
More about Osteopore Ltd.
Osteopore Limited is a medical technology company focused on regenerative solutions, operating through Osteopore and its controlled entities. The company is headquartered in Perth, Western Australia, and maintains corporate governance through a board of directors and a company secretary, with its shares administered by a professional share registry and its accounts audited by an external audit firm.
Average Trading Volume: 31,878,288
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.94M
Learn more about OSX stock on TipRanks’ Stock Analysis page.